Table 2.
Pyruvate (Pyruvic Acid) | Lactate (Lactic Acid) | |
---|---|---|
Contribution to cancer cells’ extracellular acidity | No | Strong contribution |
Conversion to acetyl CoA (active acetate) to start the cycle, ketogenesis, or lipogenesis | Directly via the enzyme pyruvate dehydrogenase. This occurs less in hyperglycolytic cancer cells due to consumption of pyruvate to form lactate and mitochondrial damage | None. Lactate must be converted first into pyruvate via LDH enzyme activity. Usually this does not occur in hyperglycolytic cancer cells due to consumption of pyruvate in forming lactate and the mitochondrial defects that impair the Krebs cycle |
Fate in hyperglycolytic cancer cells exhibiting the Warburg effect | Formed from glucose then is rapidly converted to lactate (using LDH to produce the Warburg effect) | Formed from pyruvate, then becomes extruded outside cancer cells producing acidic microenvironment and does not become pyruvate again |
Formation and transport | Mainly in normal cells' cytoplasm (from glucose oxidation), then enters the mitochondria using pyruvate translocase enzyme to give acetyl CoA to start the Krebs cycle that needs intact mitochondria and oxygen | In the cytoplasm (from pyruvate resulting from glucose oxidation). Then, lactate goes outside the cells. If lactate enters the mitochondria, it cannot be metabolized further due to mitochondrial lesions. Lactate formation is enhanced by mitochondrial lesions, and absent oxygen (in normal cells), tumour hypoxia or even in the presence of oxygen in cancer cells |
Functions in hyperglycolytic cancer cells |
|
|
Causing immunological evasion (escape) of tumours | Never | Very powerful. Lactate inhibits T lymphocytes and suppresses anticancer immunity |